simpl.
Anmelden
Life-Sciences-eQMS 13 Punkte

Combination Products cGMP Checklist (21 CFR Part 4)

Diese Checkliste ist auf Englisch.

Confirms that a drug-device or biologic-device combination product operates under a compliant streamlined cGMP approach integrating drug (211) and device (820) requirements. Use to audit combination product manufacturing.

21 CFR Part 421 CFR 21121 CFR 820

Kostenlos als PDF oder Word · E-Mail-Adresse eingeben und herunterladen.

Constituent Parts and Approach

  • Are the constituent parts of the combination product identified and classified (drug, device, biologic)? *
  • Is a compliant cGMP operating model selected (drug or device base) with the streamlined approach documented? *
  • Are the applicable base regulation requirements fully met (e.g., 21 CFR 211 for drug-led operations)? *

Called-Out Device Provisions

  • Are the called-out device provisions implemented when operating under drug cGMP (design controls 820.30)? *
  • Is purchasing control (820.50) applied to device constituent suppliers? *
  • Are corrective and preventive action (820.100) requirements implemented? *
  • Is installation (820.170) and servicing (820.200) applied where relevant?

Called-Out Drug Provisions

  • When operating under device QMS, are the called-out drug provisions implemented (211.84 component testing, 211.166 stability)? *
  • Is expiration dating (211.137) applied to drug constituents?
  • Are reserve samples (211.170) maintained where required?

Integration and Reporting

  • Are interactions between constituent parts assessed for safety and performance? *
  • Are combination product adverse event and malfunction reporting requirements met? *
  • Are labeling and human factors considerations addressed for the integrated product?

Vollständige Checkliste Combination Products cGMP Checklist (21 CFR Part 4) herunterladen

Kostenlos als übersichtliches, druckfertiges PDF oder als bearbeitbares Word-Dokument.